ISPOR ANNOUNCES CALL FOR NOMINATIONS

Published Oct 19, 2015
SUBMISSIONS BEING ACCEPTED FOR 2016-2017 BOARD OF DIRECTORS Princeton, NJ—October 19, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today that it is accepting nominations for the 2016-2017 Board of Directors. Board openings include President-Elect and four Director positions. As a member-driven organization, ISPOR relies on the participation of its members to fulfill the organization’s mission. Participating on the Board enables ISPOR members to lend their leadership, expertise, and vision to the discipline of health economics and outcomes research. The Board of Directors drives ISPOR’s strategic direction and is responsible for the management of the Society, including its committees, publications, budget and governance. The Board is the policy making body of the Society. Members may submit nominations on behalf of other ISPOR members or may self-nominate. Additional details on the nomination process may be found at http://www.ispor.org/board/CallForNominations-BOD2016.asp. Information on the 2015-2016 Board of Directors members (including terms of office) can be found at http://www.ispor.org/board/index.asp. The deadline for submitting nominations is January 1, 2016.

###

Related Stories

Promoting Fairness in Funding Decisions

Jun 24, 2026

Value in Health announced the publication of a special themed section of research papers that offer new tools to help health policy makers weigh fairness alongside cost-effectiveness when deciding which treatments and programs to fund.

Listening to Patients in the Real World

Jun 23, 2026

Value in Health, the official journal of ISPOR announced today the publication of an ISPOR Good Practices Report outlining 9 areas to strengthen the robustness, transparency, and feasibility of real-world patient-reported outcomes studies.

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×